FDA Approves New Drug to Combat Severe Chronic Eczema

Published on September 17, 2024

The U.S. Food and Drug Administration approved a new monthly injectable drug that may benefit people with moderate to severe eczema. EBGLYSS, developed by Eli Lilly, offers relief where other therapies have fallen short, potentially helping patients as young as 12 who have battled this chronic skin condition, the company said. “Patients still struggle to control their moderate-to-severe atopic dermatitis with currently available therapies. Many experience poor long-term disease control, and severe itch can significantly impact their daily lives,” said Jonathan Silverberg, professor of dermatology at George Washington University School of Medicine in the company’s press release. Topical medicines are often the first line of treatment for mild to moderate eczema, but they may not be as effective in patients with more severe disease....

Continue reading on website
Other news

Speaker Johnson Says He’ll Try to Pass Stopgap Spending Bill Despite Opposition

September 17, 2024
WASHINGTON—House Speaker Mike Johnson (R-La.) announced on Sept. 17 that his conference would stick with a temporary government funding proposal that includes an election security bill, which Democrats oppose, prolonging a Congressional impasse that could result in a government shutdown.House Republicans have demanded that a continuing resolution (CR) to temporarily fund the government after the c

Judge Denies RFK Jr.’s Bid to Withdraw From Wisconsin Ballot

September 17, 2024
A Wisconsin judge has rejected former independent presidential candidate Robert F. Kennedy Jr.’s request to have his name removed from the state’s general election ballot, opening the door for a possible appeal.In an oral ruling on Sept. 16, Dane County Circuit Judge Stephen Ehlke denied Kennedy’s motion for a temporary injunction that would have removed his name from the Wisconsin ballot.Kennedy